Clinical Trial Update: Liposomal Bupivacaine for Pain Control Following Anterior Cruciate Ligament Reconstruction [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update describing results for liposomal bupivacaine used for postoperative pain control after anterior cruciate ligament reconstruction.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anterior Cruciate Ligament Rupture

Drugs mentioned

• Exparel (liposomal bupivacaine)

Snippet

Sponsor: Emory University | Conditions: Anterior Cruciate Ligament Rupture | Phase 4 | Status: COMPLETED | Results posted: 2016-06-14